GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Healius Ltd (ASX:HLS) » Definitions » Gross-Profit-to-Asset %

Healius (ASX:HLS) Gross-Profit-to-Asset % : 44.35% (As of Dec. 2023)


View and export this data going back to 1998. Start your Free Trial

What is Healius Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Healius's annualized Gross Profit for the quarter that ended in Dec. 2023 was A$1,479 Mil. Healius's average Total Assets over the quarter that ended in Dec. 2023 was A$3,335 Mil. Therefore, Healius's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 44.35%.


Healius Gross-Profit-to-Asset % Historical Data

The historical data trend for Healius's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healius Gross-Profit-to-Asset % Chart

Healius Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.34 34.89 39.05 51.00 38.08

Healius Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.49 42.44 36.58 38.05 44.35

Competitive Comparison of Healius's Gross-Profit-to-Asset %

For the Diagnostics & Research subindustry, Healius's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healius's Gross-Profit-to-Asset % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Healius's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Healius's Gross-Profit-to-Asset % falls into.



Healius Gross-Profit-to-Asset % Calculation

Healius's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Jun. 2023 )/( (Total Assets (A: Jun. 2022 )+Total Assets (A: Jun. 2023 ))/ count )
=1483.2/( (4136.8+3653.2)/ 2 )
=1483.2/3895
=38.08 %

Healius's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2023 )/( (Total Assets (Q: Jun. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=1479/( (3653.2+3016.8)/ 2 )
=1479/3335
=44.35 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Healius Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Healius's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Healius (ASX:HLS) Business Description

Traded in Other Exchanges
N/A
Address
161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000
Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.

Healius (ASX:HLS) Headlines

No Headlines